Psychiatry · Hartford, CT
NPI
1679502140
Since 2006
Specialty
Psychiatry
Code 2084P0800X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
664 Prospect Ave
Hartford, CT, 06105
Phone (860) 236-8087
Groups this clinician bills Medicare through
Medicare paid, 2024
$20K
327 services
Medicare patients, 2024
104
Average age 66
Drug cost, 2024
$1.2M
7,291 prescriptions
Company payments, 2025
$3,641
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Steven M Katz was code 99213 (office e&m - established), 313 times for 98 patients. In total Steven M Katz billed 327 services in 3 codes, and Medicare paid $20K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-05-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 313 | 98 | $58.38 | $18K |
| 90792 Psychotherapy - Nongroup | Office | 12 | 12 | $157.65 | $1,892 |
By year: 2022 $22K for 351 services; 2023 $21K for 350 services; 2024 $20K for 327 services.
Medicare prescription drug claims, 2024
In 2024, the drug Steven M Katz prescribed most often to Medicare patients was Clonazepam, with 787 prescriptions and refills. In total Steven M Katz wrote 7,291 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Clonazepam Generic | 787 | 967 | 102 | $6,877 |
| Lorazepam Generic | 395 | 420 | 51 | $3,044 |
| Duloxetine Hcl Generic | 379 | 733 | 64 | $7,209 |
| Bupropion Xl Bupropion Hcl | 319 | 684 | 67 | $4,732 |
| Escitalopram Oxalate Generic | 313 | 627 | 59 | $2,740 |
| Alprazolam Generic | 312 | 366 | 48 | $2,397 |
| Lamotrigine Generic | 262 | 604 | 54 | $2,858 |
| Quetiapine Fumarate Generic | 251 | 450 | 50 | $6,911 |
| Venlafaxine Hcl Er Venlafaxine Hcl | 250 | 514 | 41 | $6,728 |
| Trazodone Hcl Generic | 230 | 445 | 44 | $1,695 |
| Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine | 186 | 201 | 26 | $6,555 |
| Gabapentin Generic | 165 | 243 | 27 | $2,139 |
| Dextroamphetamine-Amphet Er Dextroamphetamine/Amphetamine | 155 | 164 | 18 | $5,800 |
| Zolpidem Tartrate Generic | 145 | 177 | 20 | $3,076 |
| Buprenorphine-Naloxone Buprenorphine Hcl/Naloxone Hcl | 136 | 147 | 14 | $20K |
Brand drugs: 620 claims; generic drugs: 6,671 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Steven M Katz $3,641 ($3,641 in general payments such as food, travel and fees) from 21 companies. The largest payer was Abbvie Inc. with $575.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 39 | $575 |
| Teva Pharmaceuticals USA, Inc. TEVA | 24 | $484 |
| Neurocrine BioSciences, Inc. NBIX | 18 | $288 |
| E.R. Squibb & Sons, L.L.C. BMY | 15 | $273 |
| Corium, LLC | 23 | $273 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 18 | $259 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 13 | $245 |
| Alkermes, Inc. ALKS | 9 | $230 |
| Janssen Pharmaceuticals, Inc JNJ | 8 | $162 |
| Axsome Therapeutics, Inc. AXSM | 6 | $159 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.